The PCR product was cloned into a SalI restriction site located in the beginning of the acrD gene (pBlueKS.acrD-ext, pBlueSK.acrD-ext). Drug susceptibility tests The minimal inhibitory concentrations (MIC) of drugs for E. this website amylovora strains were determined by a 2-fold dilution assay in Mueller-Hinton broth (MHB). All tests were done

in at least triplicate following the Clinical and Laboratory Standards Institute recommendations [50]. Growth of bacteria at 28°C was examined by visual inspection after 48 h incubation. The MIC was defined as the lowest concentration of an antibiotic that completely prevented visible cell growth. Generation of promoter-EGFP fusions Transcriptional fusions between Napabucasin in vitro the promoter regions of acrA and acrD, respectively, and egfp were created using a previously described PCR-based method [51]. Briefly, a 546-bp fragment containing the TSA HDAC manufacturer upstream region of acrD was amplified using the primer acrD_up and the reverse primer acrD-P-egfp containing a 24-nt extension that is homologous to the start of the egfp gene. The acrA upstream region was amplified using the primer acrAB_fwd and the reverse primer acrA-P-egfp.

Next, the reporter gene egfp was amplified using the primer pair egfp-ATG and egfp-Cm and the plasmid pBBR.egfp.TIR [16] as the template. All PCR products were gel-purified. For the fusion reaction, 200 ng of a PCR fragment containing a promoter region were mixed with 200 ng of the reporter gene fragment. Nested primer pairs were used for the fusion PCR reactions. For fusion of the acrD promoter to the egfp gene, the primers acrD-P-fwd_SacII-2 and uidA-t0-KpnI were used. The primers acrA-P-fwd-SacII and uidA-t0-KpnI

were used in a PCR to fuse the acrA promoter to egfp. The PCR products were gel-purified to remove non-fused fragments. Next, SPTLC1 the fusion product was cloned in opposite direction to the lacZ’ promoter, into SacII-KpnI-treated pBBR1MCS, yielding plasmids pBBR.acrA-Pro.egfp and pBBR.acrD-Pro.egfp. Promoter activity of acrD in vitro The reporter gene egfp was employed to study the impact of diverse antimicrobial substances on promoter activities of acrD in E. amylovora. Plasmids carrying the transcriptional fusions were transformed into Ea1189. Antimicrobial compounds were added to the bacterial cells in 96-well microtiter plates by the 2-fold dilution method as described for MIC assays. EGFP fluorescence of the cells following exposure to various concentrations of the substrates was measured 48 hours after incubation at 28°C using the microplate reader Infinite M1000 PRO (Tecan, Crailsheim, Germany) with an excitation wavelength of 470 nm and emission detection at 516 nm. Fluorescence values obtained were plotted versus optical density in a scatter plot (see Additional file 5). A best-fit linear regression line was added to the plot and a 95% confidence interval determined.